1. Physical activity |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.36 [-1.1, 0.38] |
Very low |
It may result in little to no difference in physical activity |
0 |
0 |
[, ] |
NA |
1.0 |
-0.36 [-1.1, 0.38] |
Low |
2. Weight (management) / Weight (Kgs/lbs) |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-6.16 [-13.76, 1.44] |
Very low |
It may result in little to no difference in weight (kgs) but the evidence is very uncertain |
0 |
0 |
[, ] |
NA |
1.0 |
-6.16 [-13.76, 1.44] |
Low |
3. Lipid profile / Triglycerides |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-2.27 [-4.15, -0.38] |
Very low |
It may decrease triglycerides (mmol/L) but the evidence is very uncertain |
0 |
0 |
[, ] |
NA |
1.0 |
-2.27 [-4.15, -0.38] |
Moderate |
4. Weight (management) / BMI - Body Mass Index |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
0.87 [-1.46, 3.2] |
Moderate |
It likely results in little to no difference in body mass index (kg/m²) |
0 |
0 |
[, ] |
NA |
1.0 |
0.87 [-1.46, 3.2] |
Low |
5. Lipid profile / LDL-Cholesterol |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-4.03 [-12.63, 4.56] |
Moderate |
It likely results in little to no difference in LDL levels (mg/dL) |
0 |
0 |
[, ] |
NA |
3.0 |
-4.03 [-12.63, 4.56] |
0 |
6. Self-monitoring / Glucose self-monitoring |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.92 [-2.14, 0.29] |
Very low |
It may decrease glucose self-monitoring but the evidence is very uncertain |
0 |
0 |
[, ] |
NA |
1.0 |
-0.92 [-2.14, 0.29] |
Low |
7. Knowledge |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.13 [-1.35, 1.1] |
Very low |
It may result in little to no difference in knowledge but the evidence is very uncertain |
0 |
0 |
[, ] |
NA |
1.0 |
-0.13 [-1.35, 1.1] |
Low |
8. Dietary habits |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
1.07 [0.19, 1.96] |
Low |
It may improve dietary habits |
0 |
0 |
[, ] |
N/A |
1.0 |
1.07 [0.19, 1.96] |
Low |
9. Quality of life / Psychological distress |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.25 [-0.74, 0.24] |
Very low |
It may result in little to no difference in psychological distress but the evidence is very uncertain |
2 |
91 |
-0.32 [-0.88, 0.25] |
Low |
1.0 |
-0.05 [-1.05, 0.94] |
Low |
10. Quality of life |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
0.45 [-0.26, 1.16] |
Very Low |
It may result in little to no difference in quality of life but the evidence is very uncertain |
1 |
49 |
0.23 [-0.72, 1.17] |
Low |
1.0 |
0.74 [-0.34, 1.82] |
Low |
11. Adherence / Medication (or other treatment) adherence |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.02 [-0.83, 0.8] |
Very low |
It may result in little to no difference in adherence |
2 |
2173 |
0.15 [-0.83, 1.12] |
Low |
1.0 |
-0.39 [-1.87, 1.09] |
Low |
12. HbA1C / Glycated hemoglobin (HbA1c) |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-0.33 [-0.72, 0.06] |
Very low |
It may result in little to no difference in HbA1C levels (%) but the evidence is very uncertain |
2 |
253 |
-0.13 [-0.75, 0.49] |
Low |
3.0 |
-0.46 [-0.96, 0.04] |
Low |
13. Blood-pressure / Diastolic pressure |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
0.53 [-2.93, 3.99] |
Very low |
It may result in little to no difference in diastolic blood pressure(mmHg) but the evidence is very uncertain |
1 |
204 |
-0.75 [-6.96, 5.46] |
Low |
1.0 |
1.1 [-3.07, 5.27] |
Low |
14. Blood-pressure / Systolic pressure |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
-1.12 [-6.92, 4.69] |
Very low |
It may decrease systolic blood pressure levels (mmHg) but the evidence is very uncertain |
1 |
204 |
-2.92 [-11.09, 5.25] |
Low |
1.0 |
0.73 [-7.53, 8.99] |
Low |
15. Lipid profile / Total cholesterol |
NMA |
Direct |
Indirect |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Interpretation of findings |
Number of studies |
Number of patients |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
Number of comparisons informing indirect evidence |
Anticipated absolute effects (95% CI) - Difference |
Certainty of the evidence |
4.73 [-8.62, 18.08] |
Moderate |
It likely results in little to no difference on total cholesterol (mg/dL) |
1 |
204 |
4.73 [-8.62, 18.08] |
Moderate |
0.0 |
NA [NA, NA] |
NA |
Footnotes per outcome:
1) a) We rated down the certainty of evidence due to very serious risk of bias and serious imprecision; b) Number of studies included in the network: 64 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 24 months for the studies included in the whole network. 2) a) Number of studies included in the network: 145 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 51 months for the studies included in the whole network; b) We rated down the certainty of evidence due to serious imprecision 3) a) Number of studies included in the network: 171 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network; b) We rated down the certainty of evidence due to serious risk of bias and serious imprecision 4) a) We rated down the certainty of evidence due to serious imprecision; b) Number of studies included in the network: 231 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s).The range of follow up was from 1 to 96 months for the studies included in the whole network. 5) a) We rated down the certainty of evidence due to serious risk of bias; b) Number of studies included in the network: 171 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 3 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network. 6) a) We rated down the certainty of evidence due to very serious risk of bias and serious imprecision; b) Number of studies included in the network: 29 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 2 to 24 months for the studies included in the whole network. 7) a) Number of studies included in the network: 43 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: comparison(s). The range of follow up was from 2 to 60 months for the studies included in the whole network. The range of follow-up was months in the studies directly comparing the self-management intervention versus usual care; b) We rated down the certainty of evidence due to very serious imprecision and serious risk of bias 8) a) Number of studies included in the network: 30 RCTs; Number of studies directly comparing the intervention with usual care: 0 RCT(s) (N=0); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 24 months for the studies included in the whole network; b) We rated down the certainty of evidence due to serious imprecision 9) a) We rated down the certainty of evidence due to very serious risk of bias and serious imprecision; b) Number of studies included in the network: 44 RCTs; Number of studies directly comparing the intervention with usual care: 2 RCT(s) (N=52); Number of comparison(s) informing the indirect estimate: 1 comparison(s).The range of follow up was from 2 to 24 months for the studies included in the whole network. The range of follow-up was 2-6 months in the studies directly comparing the self-management intervention versus usual care. 10) a) Number of studies included in the network: 81 RCTs; Number of studies directly comparing the intervention with usual care: 1 RCT(s) (N=27); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 60 months for the studies included in the whole network. The range of follow-up was 6 months in the studies directly comparing the self-management intervention versus usual care.; b) We rated down the certainty of evidence due to serious imprecision 11) a) Number of studies included in the network: 55 RCTs; Number of studies directly comparing the intervention with usual care: 2 RCT(s) (N=1106); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 24 months for the studies included in the whole network. The range of follow-up was 2-6 months in the studies directly comparing the self-management intervention versus usual care.; b) We rated down the certainty of evidence due to very serious imprecision and very serious risk of bias 12) a) We rated down the certainty of evidence due to serious imprecision, serious risk of bias and serious inconsistency; b) Number of studies included in the network: 463 RCTs; Number of studies directly comparing the intervention with usual care: 2 RCT(s) (N=130); Number of comparison(s) informing the indirect estimate: 3 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network. The range of follow-up was 6-12 months in the studies directly comparing the self-management intervention versus usual care. 13) a) Number of studies included in the network: 211 RCTs; Number of studies directly comparing the intervention with usual care: 1 RCT(s) (N=103); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network. The range of follow-up was 12 months in the studies directly comparing the self-management intervention versus usual care.; b) We rated down the certainty of evidence due to very serious risk of bias and very serious imprecision 14) a) We rated down the certainty of evidence due to very serious risk of bias and serious imprecision; b) Number of studies included in the network: 233 RCTs; Number of studies directly comparing the intervention with usual care: 1 RCT(s) (N=103); Number of comparison(s) informing the indirect estimate: 1 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network. The range of follow-up was 12 months in the studies directly comparing the self-management intervention versus usual care. 15) a) Number of studies included in the network: 176 RCTs; Number of studies directly comparing the intervention with usual care: 1 RCT(s) (N=103); Number of comparison(s) informing the indirect estimate: 0 comparison(s). The range of follow up was from 1 to 96 months for the studies included in the whole network. The range of follow-up was 12 months in the studies directly comparing the self-management intervention versus usual care.; b) We rated down the certainty of evidence due to serious risk of bias
References of studies informing direct evidence:
9) Cohn-2014; Wolever-2010 10) Wolever-2010 11) O'Connor-2014, Wolever-2010 12) Mons-2013, Wolever-2010 13) Mons-2013 14) Mons-2013 15) Mons-2013
|